Ahn-Gook Pharmaceutical Co Ltd
KOSDAQ:001540
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Wiz Co Participacoes e Corretagem de Seguros SA
BOVESPA:WIZC3
|
BR |
|
AES Brasil Energia SA
BOVESPA:AESB3
|
BR |
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| KR |
A
|
Ahn-Gook Pharmaceutical Co Ltd
KOSDAQ:001540
|
88.4B KRW |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
161B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120B USD |
Loading...
|
Market Distribution
| Min | -168 471.3% |
| 30th Percentile | -2.9% |
| Median | 1.9% |
| 70th Percentile | 5.8% |
| Max | 21 012.5% |
Other Profitability Ratios
Ahn-Gook Pharmaceutical Co Ltd
Glance View
AHN-GOOK PHARMACEUTICAL Co., Ltd. engages in the development, production, and sale of pharmaceutical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2000-06-15. The Company’s products include respiratory agents, gastrointestinal agents, anti-inflammatory, analgesic agents, ophthalmic agents and circulatory system agents. The company also provides antibiotic, antifungal drugs, antihyperlipidemic agents, antiallergic drugs, anti-diabetic drugs, urinary system drugs and skin disease remedies. In addition, the Company provides other over the counter (OTC) and ethical (ETC) drugs. The firm distributes its product within domestic market and to overseas markets.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Ahn-Gook Pharmaceutical Co Ltd is 3.3%, which is below its 3-year median of 3.6%.
Over the last 3 years, Ahn-Gook Pharmaceutical Co Ltd’s Net Margin has decreased from 4.8% to 3.3%. During this period, it reached a low of 0.6% on Dec 31, 2023 and a high of 6.2% on Dec 31, 2024.
